Global E-cigarette Leader Smoore Faces Competition Challenges

Aug.08.2022
China's largest e-cigarette company, Smoore International, faces competition as other companies receive tobacco production licenses.

The world's largest electronic cigarette company, Smoore International (06969.HK), is facing a challenge.


Recently, it was announced by Smore International that three fully-owned subsidiaries have received the Tobacco Monopoly Administration's Production License for Tobacco Monopoly Enterprises.


In the past two years, as regulations for electronic cigarettes have been gradually issued, the industry is moving towards standardization. Data shows that by 2022, the global electronic cigarette market will exceed $108 billion, attracting many industry giants to enter the market.


On the same day that the above notice was released, BYD Electronic and Jingjia Stock also announced that their subsidiaries had obtained exclusive production licenses. This has intensified the competition faced by SMOORE International.


A journalist from China Yangtze Daily noticed that in 2021, Smoore International held a global market share of 22.8%, exceeding the sum of the second to fifth largest companies, and maintained its position as the world's largest manufacturer of electronic atomization devices.


However, after moving towards standardization, the "age of profiteering" for the electronic cigarette industry will become a thing of the past. In the first half of this year, Smoore International's net profit is expected to decline by 46.0% to 53.8% year-on-year.


The industry is rapidly developing and enterprises are increasingly entering cross-border markets.


As the "Electronic Cigarette Management Measures" and mandatory national standards for electronic cigarettes have been introduced this year, the electronic cigarette industry is facing significant changes and gradually moving towards standardization.


Recently, Smoore International announced that its subsidiary has obtained a license to produce tobacco products. The company expressed confidence in its future development and stated that its overall production and operations will continue as planned. The company also affirmed its commitment to comply with relevant national policies and operate within the confines of the law.


According to data, the global electronic cigarette market size is expected to exceed $108 billion by 2022, with overseas markets sustaining a growth rate of 35%. Currently, there are over 1,500 electronic cigarette manufacturers and brands in China, with over 70% of them focused on exporting products overseas. Last year, Chinese electronic cigarette exports reached ¥138.3 billion, a year-on-year increase of 180%; it is expected that the total export value of electronic cigarettes for the whole year will reach ¥186.7 billion, with a growth rate of 35%.


The electronic cigarette industry is rapidly developing, with many large domestic companies diversifying into it. Manufacturing giants like Luxshare Precision, as well as Jingjia Allocation, Jinlong Machinery & Electronics, Shunhao Allocation, Jincheng Medicine, Boteng Allocation, and Huabao Allocation, have successively obtained production qualifications for electronic cigarettes. According to incomplete statistics, more than 130 enterprises have received compliant certificates as of now.


One notable development in the electronics industry is BYD's entry into the electronic cigarette market. Since 2018, BYD Electronics has been laying the groundwork for its electronic cigarette products, having completed patent layouts for its complete range of vaporization products, investment in automated production lines, and the integration of research and development of new materials, precision moulds, product design and development, as well as intelligent manufacturing capabilities.


Abundant production capacity leads to an increase in market share.


Despite facing increasingly fierce competition, Smurfit Kappa, as the industry leader, currently holds a relatively stable position.


In 2021, SMIC held a global market share of 22.8%, surpassing the combined total of second through fifth place. Furthermore, the company has ample production capacity with a scale of 2.59 billion standard units per year in 2021. The completion of its Jiangmen phases one and two will raise its total production capacity to over five billion standard units per year.


However, with the adjustments to regulations in the e-cigarette industry, the era of "excessive profits" will become a thing of the past. As a result, Smoore International experienced a decline in revenue growth during the first half of this year.


According to its recently released performance forecast, the company is expected to generate revenue of approximately RMB 1.322 billion to RMB 1.554 billion in the first half of the year, representing a year-on-year decrease of about 46.0% to 54.1%. The net profit is estimated to be about RMB 1.375 billion to RMB 1.606 billion, representing a year-on-year decrease of about 46.0% to 53.8%.


Simo International has announced a projected 50% decrease in revenue and net profit, citing reduced income from the Chinese market and a shift in product mix leading to lower gross margins. The company also reported significant increases in research and development expenses, management fees, and sales costs as it seeks to bolster its growth prospects in new areas.


It is worth mentioning that in terms of overseas business, Smoore International's major client under the British and American Tobacco umbrella, Vuse brand, has had three products approved through the Pre-Market Tobacco Product Application (PMTA), validating the company's supply chain capabilities. Additionally, the company's contract-manufactured disposable product Vuse go has been launched in non-US markets in Q2, and there will be a rapid increase in production of disposable products in the second half of the year, leading to an expected acceleration of overseas revenue growth in the latter half of the year.


In addition, Sumore International has increased its investment in research and development, with more than 3,000 patent applications filed to date. In 2021, the company's research and development expenses amounted to 670 million yuan, representing a year-on-year increase of 59.7%.


This article contains excerpts or reprints from third-party sources, which are owned by the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual that needs to reprint must contact the author and must not reprint directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands (TPB) reported third-quarter 2026 Modern Oral net sales of $74.4 million on November 9, up 102.9% year over year and representing 49.2% of consolidated net sales. Total company net sales rose 27.0% to $151.1 million, while net income attributable to TPB declined 81.4% to $3.93 million. The company is expanding the US retail presence of its FRE and ALP nicotine pouch brands and expects its Modern Oral chain-store footprint to grow by more than 70% during 2026. Selling, general and administrative expenses increased 69.1% to $75.3 million, while PMTA-related expenses reached approximately $3.15 million and manufacturing start-up costs totaled about $593,000. ALP plans to open a branded pop-up in New York City's SoHo neighborhood on November 13, alongside a marketing campaign extending into January 2027. TPB owns 50% of ALP but consolidates the venture in its financial statements.
company
Nov.11
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23